Literature DB >> 27180315

Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.

Nai-Dan Zhang1, Ting Han1, Bao-Kang Huang1, Khalid Rahman2, Yi-Ping Jiang1, Hong-Tao Xu1, Lu-Ping Qin1, Hai-Liang Xin3, Qiao-Yan Zhang4, Yi-Min Li1.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Osteoporosis is a chronic epidemic which can leads to enhanced bone fragility and consequent an increase in fracture risk. Traditional Chinese medicine (TCM) formulas have a long history of use in the prevention and treatment of osteoporosis. Antiosteoporotic TCM formulas have conspicuous advantage over single drugs. Systematic data mining of the existing antiosteoporotic TCM formulas database can certainly help the drug discovery processes and help the identification of safe candidates with synergistic formulations. In this review, the authors summarize the clinical use and animal experiments of TCM formulas and their mechanism of action, and discuss the potential antiosteoporotic activity and the active constituents of commonly used herbs in TCM formulas for the therapy of osteoporosis.
MATERIALS AND METHODS: The literature was searched from Medline, Pubmed, ScienceDirect, Spring Link, Web of Science, CNKI and VIP database from 1989 to 2015, and also collected from Chinese traditional books and Chinese Pharmacopoeia with key words such as osteoporosis, osteoblast, osteoclast, traditional Chinese medicine formulas to identify studies on the antiosteoporotic effects of TCM formulas, herbs and chemical constituents, and also their possible mechanisms.
RESULTS: Thirty-three TCM formulas were commonly used to treat osteoporosis, and showed significant antiosteoporotic effects in human and animal. The herb medicines and their chemical constituents in TCM formulas were summarized, the pharmacological effects and chemical constituents of commonly used herbs in TCM formulas were described in detail. The action mechanisms of TCM formulas and their chemical constituents were described. Finally, the implication for the discovery of antiosteoporotic leads and combinatory ingredients from TCM formulas were prospectively discussed.
CONCLUSIONS: Clinical practice and animal experiments indicate that TCM formulas provide a definite therapeutic effect on osteoporosis. The active constituents in TCM formulas are diverse in chemical structure, and include flavonoids, lignans, saponins and iridoid glycosides. Antiosteoporotic mechanism of TCM formulas and herbs involves multi regulatory pathways, such as Wnt/β-catenin, BMP/Smad, MAPK pathway and RANKL/OPG system. Phytochemicals from TCM formulas and their compositional herb medicines offer great potential for the development of novel antiosteoporotic drugs. The active ingredients in TCM formulas can be developed in combination as potent drugs, which may exhibit better antiosteoporotic effects compared to the individual compound.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Action mechanism; Active ingredients; AsperosaponinⅥ (PubChem CID: 71307450); Aucubin (PubChem CID: 91458); Catalpol (PubChem CID: 91520); Cinnamaldehyde (PubChem CID: 637511); Clinical use; Ecdysterone (PubChem CID: 271605); Emodin (PubChem CID: 3220); Ferulic acid (PubChem CID: 445858); Formononetin (PubChem CID: 5280378); Kaempferol (PubChem CID: 5280863); Osteoporosis; Sweroside (PubChem CID: 161036); Traditional Chinese medicine formulas

Mesh:

Substances:

Year:  2016        PMID: 27180315     DOI: 10.1016/j.jep.2016.05.025

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  53 in total

1.  Effect of Rhizoma Drynariae on differential gene expression in ovariectomized rats with osteoporosis based on transcriptome sequencing.

Authors:  Hui Su; Haipeng Xue; Shang Gao; Binghan Yan; Ruochong Wang; Guoqing Tan; Zhanwang Xu; Lingfeng Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-02       Impact factor: 6.055

2.  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study of Jianyao Migu Granules in the Treatment of Osteopenic Low Back Pain.

Authors:  Zihao Qin; Ke Xu; Wen Mo; Jie Ye; Jinhai Xu
Journal:  J Pain Res       Date:  2022-09-01       Impact factor: 2.832

3.  Epimedin C Alleviates Glucocorticoid-Induced Suppression of Osteogenic Differentiation by Modulating PI3K/AKT/RUNX2 Signaling Pathway.

Authors:  Yongxiang Xu; Shichun Chen; Linxuan Huang; Weichao Han; Yingying Shao; Minyi Chen; Yusheng Zhang; Ruirong He; Baocheng Xie
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

Review 4.  Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease Complicated With Osteoporosis.

Authors:  Weifan Xu; Yiping Jiang; Nani Wang; Huanhuan Bai; Shengyan Xu; Tianshuang Xia; Hailiang Xin
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

Review 5.  Evolving Roles of Natural Terpenoids From Traditional Chinese Medicine in the Treatment of Osteoporosis.

Authors:  Yue Zhuo; Meng Li; Qiyao Jiang; Hanzhong Ke; Qingchun Liang; Ling-Feng Zeng; Jiansong Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

Review 6.  Traditional Chinese medicine promotes bone regeneration in bone tissue engineering.

Authors:  Zheng-Rong Gao; Yun-Zhi Feng; Ya-Qiong Zhao; Jie Zhao; Ying-Hui Zhou; Qin Ye; Yun Chen; Li Tan; Shao-Hui Zhang; Yao Feng; Jing Hu; Ze-Yue Ou-Yang; Marie Aimee Dusenge; Yue Guo
Journal:  Chin Med       Date:  2022-07-20       Impact factor: 4.546

7.  Overexpression of CAV3 facilitates bone formation via the Wnt signaling pathway in osteoporotic rats.

Authors:  Run-Bao Yang; Feng-Fei Lin; Jun Yang; Bin Chen; Ming-Hua Zhang; Qiao-Ping Lu; Bo Xiao; Yan Liu; Ke Zheng; Yong-Rong Qiu
Journal:  Endocrine       Date:  2018-11-14       Impact factor: 3.925

8.  Network Pharmacological Study on Mechanism of the Therapeutic Effect of Modified Duhuo Jisheng Decoction in Osteoporosis.

Authors:  Xudong Huang; Zhou Zhou; Yingyi Zheng; Guoshuai Fan; Baihe Ni; Meichen Liu; Minghua Zhao; Lingfeng Zeng; Weiguo Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

Review 9.  Genus Tinospora: Ethnopharmacology, Phytochemistry, and Pharmacology.

Authors:  Sensen Chi; Gaimei She; Dan Han; Weihua Wang; Zhao Liu; Bin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-28       Impact factor: 2.629

Review 10.  Role of gut microbiota in identification of novel TCM-derived active metabolites.

Authors:  Tzu-Lung Lin; Chia-Chen Lu; Wei-Fan Lai; Ting-Shu Wu; Jang-Jih Lu; Young-Mao Chen; Chi-Meng Tzeng; Hong-Tao Liu; Hong Wei; Hsin-Chih Lai
Journal:  Protein Cell       Date:  2020-09-15       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.